SCHEMBL6537795

SCHEMBL6537795

Cc1cccc(C(=O)Nc2cccc3cc(Br)cnc23)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.70
RAB9A P51151 4/20 0.70
KMT2A Q03164 5/20 0.58
MEN1 O00255 4/20 0.58
KDR P35968 3/20 0.56
TDP1 Q9NUW8 1/20 0.52
CASP3 P42574 1/20 0.52
SENP8 Q96LD8 1/20 0.52
SENP7 Q9BQF6 1/20 0.52
SENP6 Q9GZR1 1/20 0.52
L3MBTL1 Q9Y468 2/20 0.50
MAPT P10636 2/20 0.49
TP53 P04637 1/20 0.49
HTT P42858 2/20 0.49
GRM5 P41594 1/20 0.49
GPR35 Q9HC97 1/20 0.48
LMNA P02545 1/20 0.48
KCNK3 O14649 1/20 0.48
KCNH2 Q12809 1/20 0.48
KCNK9 Q9NPC2 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537976 0.89 TDP1 (0.60) NPC1RAB9AKMT2AKDRTDP1
SCHEMBL6537872 0.86 KDR (0.57) NPC1RAB9AKMT2AMEN1KDR
SCHEMBL6537930 0.86 KDR (0.54) NPC1RAB9AKMT2AMEN1KDR
SCHEMBL6537334 0.85 L3MBTL1 (0.70) NPC1RAB9AKMT2AMEN1KDR
SCHEMBL6538118 0.85 KDR (0.56) NPC1RAB9AKMT2AMEN1KDR
SCHEMBL6537710 0.85 KDR (0.53) NPC1RAB9AKMT2AMEN1KDR
SCHEMBL6537714 0.85 KMT2A (0.61) NPC1RAB9AKMT2AMEN1KDR
SCHEMBL6538099 0.85 CLK1 (0.55) NPC1RAB9AKMT2AMEN1KDR
SCHEMBL6537726 0.82 TDP1 (0.61) NPC1RAB9AKMT2AMEN1KDR
SCHEMBL19748416 0.82 RAB9A (1.00) NPC1RAB9AKMT2AMEN1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed